FDA WARNING_LETTER - Trippo International LLC - January 25, 2021
On March 10, 2021, the FDA issued a Warning Letter to Mr. Azhar regarding the 16-ounce Super Caffeine (Anhydrous) product, labeled as a dietary supplement and sold on wholesalecentral.com/trippo/store.cfm.
The FDA's January 2021 review of the product's label determined it to be adulterated under section 402(f)(1)(A)(i) of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. § 342(f)(1)(A)(i)]. The product, a powdered form of caffeine anhydrous, presents a significant or unreasonable risk of illness or injury under its recommended conditions of use.
The label states a "Serving Size: 200 milligrams" with "Total Servings Per Container 2267" and "Recommended use 200mg up to 2 times daily." The FDA found that 200 milligrams cannot be accurately measured with common household tools, and a simple measurement error (e.g., grams instead of milligrams) could lead to a dangerous or toxic dose. A single teaspoon of pure powdered caffeine is approximately 2.7 grams, equivalent to 28 cups of coffee, and can cause severe symptoms or even death. The 16-ounce package contains approximately 454 grams, over 2,00
ID · 95be7ef2-c6bf-4e9a-99c1-43f53d0eaf71
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.